# OnCo record nct04188548 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04188548/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04188548", "NCT04188548" ;
  schema:name "EMBER imlunestrant early study"@en ;
  schema:alternateName "A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer"@en ;
  schema:description "This early study tests imlunestrant, originally called LY3484356, alone or with other cancer therapies. It studies safety and activity in advanced breast or endometrial cancer."@en ;
  schema:url <https://onco.cc/trials/nct04188548/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04188548>, <https://clinicaltrials.ucsf.edu/trial/NCT04188548> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "1" ;
  schema:startDate "2019-12-10" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/>, <https://onco.cc/drugs/alpelisib/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/imlunestrant/>, <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .